EP 1483293 A2 20041208 - USE OF AN ACTIVE SUBSTANCE THAT BINDS TO CD28 FOR PRODUCING A PHARMACEUTICAL COMPOSITION
Title (en)
USE OF AN ACTIVE SUBSTANCE THAT BINDS TO CD28 FOR PRODUCING A PHARMACEUTICAL COMPOSITION
Title (de)
VERWENDUNG EINER AN CD28 BINDENDEN WIRKSUBSTANZ ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG
Title (fr)
UTILISATION D'UNE SUBSTANCE ACTIVE SE LIANT A CD28 POUR LA PREPARATION D'UNE COMPOSITION PHARMACEUTIQUE
Publication
Application
Priority
- DE 0300890 W 20030313
- DE 10212108 A 20020313
Abstract (en)
[origin: WO03078468A2] The invention relates to the use of a superagonistic CD28-specific monoclonal antibody (mAb) or a mimic compound of the same, for producing a pharmaceutical composition for the induction and/or reproduction of regulatory T-cells.
IPC 1-7
IPC 8 full level
C07K 16/28 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61K 35/17 (2013.01 - EP US); A61K 39/3955 (2013.01 - US); A61P 37/02 (2018.01 - EP); C07K 16/2818 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US); C07K 2317/56 (2013.01 - EP US)
Citation (examination)
SUNTHARALINGAM GANESH ET AL: "Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412", NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US, vol. 355, no. 10, 7 September 2006 (2006-09-07), pages 1018 - 1028, XP002559375, ISSN: 0028-4793, [retrieved on 20060814], DOI: 10.1056/NEJMOA063842
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03078468 A2 20030925; WO 03078468 A3 20040212; AU 2003221604 A1 20030929; AU 2003221604 A8 20030929; DE 10212108 A1 20031002; EP 1483293 A2 20041208; US 2004092718 A1 20040513; US 2006188493 A1 20060824; US 2007134240 A1 20070614; US 2009246204 A1 20091001; US 2013266577 A1 20131010; US 8389016 B2 20130305
DOCDB simple family (application)
DE 0300890 W 20030313; AU 2003221604 A 20030313; DE 10212108 A 20020313; EP 03717153 A 20030313; US 201313783959 A 20130304; US 25103908 A 20081014; US 38967903 A 20030313; US 50779805 A 20050621; US 58548406 A 20061024